1466 related articles for article (PubMed ID: 2582053)
1. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
2. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
Kern DE; Klarnet JP; Cheever MA; Greenberg PD
Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
[TBL] [Abstract][Full Text] [Related]
3. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
Kern DE; Klarnet JP; Jensen MC; Greenberg PD
J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
[TBL] [Abstract][Full Text] [Related]
4. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
Engers HD; Lahaye T; Sorenson GD; Glasebrook AL; Horvath C; Brunner KT
J Immunol; 1984 Sep; 133(3):1664-70. PubMed ID: 6205090
[TBL] [Abstract][Full Text] [Related]
5. Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor.
Kern DE; Peace DJ; Klarnet JP; Cheever MA; Greenberg PD
J Immunol; 1988 Oct; 141(8):2824-30. PubMed ID: 2459230
[TBL] [Abstract][Full Text] [Related]
6. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
7. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
Azuma H; Phillips JD; Green WR
J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
[TBL] [Abstract][Full Text] [Related]
8. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
[TBL] [Abstract][Full Text] [Related]
9. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
Browning MJ; Huang AS; Reiss CS
J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
[TBL] [Abstract][Full Text] [Related]
10. T cell recognition of Moloney leukemia virus proteins. III. T cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes.
Ihle JN; Lee JC; Rebar L
J Immunol; 1981 Dec; 127(6):2565-70. PubMed ID: 6795277
[TBL] [Abstract][Full Text] [Related]
11. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
[TBL] [Abstract][Full Text] [Related]
12. Induction and activity of class II-restricted, Lyt-2+ cytolytic T lymphocytes specific for the influenza H5 hemagglutinin.
Hioe CE; Hinshaw VS
J Immunol; 1989 Apr; 142(7):2482-8. PubMed ID: 2466897
[TBL] [Abstract][Full Text] [Related]
13. The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clones.
Hecht TT; Longo DL; Matis LA
J Immunol; 1983 Sep; 131(3):1049-55. PubMed ID: 6193170
[TBL] [Abstract][Full Text] [Related]
14. Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human interleukin 2: correlation with clonal IL 2 receptor expression.
Matis LA; Shu S; Groves ES; Zinn S; Chou T; Kruisbeek AM; Rosenstein M; Rosenberg SA
J Immunol; 1986 May; 136(9):3496-501. PubMed ID: 2420893
[TBL] [Abstract][Full Text] [Related]
15. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
16. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
[TBL] [Abstract][Full Text] [Related]
17. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
Manjunath R; Graziano RF; Green WR
J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
[TBL] [Abstract][Full Text] [Related]
18. Activation of Lyt-1+ and Lyt-2+ T cell cloned lines: stimulation of proliferation, lymphokine production, and self-destruction.
Conta BS; Powell MB; Ruddle NH
J Immunol; 1985 Apr; 134(4):2185-90. PubMed ID: 2579131
[TBL] [Abstract][Full Text] [Related]
19. Antigen form influences induction and frequency of influenza-specific class I and class II MHC-restricted cytolytic T lymphocytes.
Morrison LA; Braciale VL; Braciale TJ
J Immunol; 1988 Jul; 141(2):363-8. PubMed ID: 2454989
[TBL] [Abstract][Full Text] [Related]
20. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
